|
JAMA Oncology |
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non Small Cell Lung Cancer |
1 |
Yes |
4/11/2027 |
|
JAMA Oncology |
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes - A Review |
1 |
Yes |
5/9/2027 |
|
JAMA Oncology |
Obstacles to Biosimilar Acceptance and Uptake in Oncology - A Review |
1 |
Yes |
5/30/2027 |
|
JAMA Oncology |
Lymphoma With a Skin Rash |
1 |
Yes |
6/6/2027 |
|
JAMA Oncology |
Current Management of Desmoid Tumors - A Review |
1 |
Yes |
6/20/2027 |
|
JAMA Oncology |
A Case of Gastric Thickening and a Large Ovarian Mass |
1 |
Yes |
6/27/2027 |
|
JAMA Oncology |
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement |
1 |
Yes |
7/11/2027 |
|
JAMA Oncology |
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients - A Review |
1 |
Yes |
7/25/2027 |
|
JAMA Oncology |
Contemporary Management of Acute Myeloid Leukemia - A Review |
1 |
Yes |
8/8/2027 |
|
JAMA Oncology |
An Anal Lesion in a 27-Year-Old Patient |
1 |
Yes |
8/22/2027 |
|
JAMA Oncology |
Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers - A Systematic Review |
1 |
Yes |
8/29/2027 |
|
JAMA Oncology |
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer - A Review |
1 |
Yes |
9/12/2027 |
|
JAMA Oncology |
Recurrent Fevers in a Patient With Splenomegaly |
1 |
Yes |
9/26/2027 |
|
JAMA Oncology |
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs |
1 |
Yes |
10/3/2027 |
|
JAMA Oncology |
Endometrial Cancer Classification and Management in the Molecular Subtyping Era |
1 |
Yes |
10/10/2027 |
|
JAMA Oncology |
Hairy Kidneys and Sclerotic Bone Lesions |
1 |
Yes |
10/24/2027 |
|
JAMA Oncology |
Advancing Global Pharmacoequity in Oncology |
1 |
Yes |
11/14/2027 |
|
JAMA Oncology |
Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers - A Review |
1 |
Yes |
11/27/2027 |
|
JAMA Oncology |
Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy - A Review |
1 |
Yes |
12/12/2027 |
|
JAMA Oncology |
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors - A Review |
1 |
Yes |
12/26/2027 |
